Previous 10 | Next 10 |
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the addition of Terilyn Juarez Monroe as the company’s chief people officer, effective immediately. In the newly-created role, Monroe will lead the human resources function, including people opera...
2023-12-21 09:10:26 ET More on Guardant Health Guardant Health: Vast Market Opportunity, Challenging Valuation Guardant Health stock slides, Exact Sciences gains amid FDA update FDA panel to review Guardant Health colorectal test on March 28 For further detai...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that it has entered into a common stock purchase agreement with Baillie Gifford on behalf of accounts that it manages for the sale of 3,387,446 shares of its common stock in a registered direct offering at a...
2023-12-21 07:05:33 ET Summary Guardant Health is a leader in liquid biopsy testing for advanced cancer patients. The company's growth is decelerating, and it is burning a significant amount of cash. The current valuation may be difficult to justify unless growth reaccelerates...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the upcoming 42 nd Annual J.P. Morgan Healthcare Conference in San Francisco. Guardant Health’s management is scheduled to present and participate in a Q&A ...
2023-12-20 11:38:11 ET More on Guardant Health Guardant Health, Inc. (GH) Q3 2023 Earnings Call Transcript Guardant Health, Inc. 2023 Q3 - Results - Earnings Call Presentation Guardant Health: Peeling Back Economic Layers, Compressed Market Values Appear Justified ...
2023-12-19 16:50:11 ET Gainers: Shimmick Corporation ( SHIM ) +11% . Westport Fuel Systems ( WPRT ) +5% . Telos Corporation ( TLS ) +2% . NN ( NNBR ) +2% . CureVac ( CVAC ) +2% . Losers: Guardant Health ( GH...
2023-12-19 16:19:54 ET More on Guardant Health Guardant Health, Inc. (GH) Q3 2023 Earnings Call Transcript Guardant Health, Inc. 2023 Q3 - Results - Earnings Call Presentation Guardant Health: Peeling Back Economic Layers, Compressed Market Values Appear Justified ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the U.S. Food and Drug Administration’s Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee is tentatively scheduled to review the premarket approval application (PMA)...
Not intended for distribution to U.S. newswire services or for dissemination in the U.S. RED DEER, AB / ACCESSWIRE / December 19, 2023 / Gamehost Inc. ('Gamehost', the 'Company') (TSX:GH) Gamehost has declared a cash dividend for the month of December 2023 of $0.04 (CDN) per common share, w...
News, Short Squeeze, Breakout and More Instantly...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the second quarter 2024 after market close on Wednesday, August 7, 2024. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Ti...
Running on Guardant Infinity™ smart liquid biopsy platform, new Guardant360 test covers over 10 times more genes, including all guideline-recommended genomic biomarkers across advanced solid tumors, and quantifies tumor burden with 10 times higher sensitivity Upgraded test covered ...
2024-07-21 23:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...